0000897069-21-000216.txt : 20210506 0000897069-21-000216.hdr.sgml : 20210506 20210506123232 ACCESSION NUMBER: 0000897069-21-000216 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210506 DATE AS OF CHANGE: 20210506 EFFECTIVENESS DATE: 20210506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cambrian BioPharma Inc CENTRAL INDEX KEY: 0001797409 IRS NUMBER: 842985609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-398458 FILM NUMBER: 21896766 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: #66643 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (516) 962-3186 MAIL ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: #66643 CITY: NEW YORK STATE: NY ZIP: 10003 FORMER COMPANY: FORMER CONFORMED NAME: Cambrian BioPharma Inc. DATE OF NAME CHANGE: 20191219 D 1 primary_doc.xml X0708 D LIVE 0001797409 Cambrian BioPharma Inc 228 Park Avenue S. #66643 New York NY NEW YORK 10003 (516) 962-3186 DELAWARE Cambrian BioPharma Inc. Corporation true 2019 James G. Peyer 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Executive Officer Director Promoter Christian Angermeyer 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Director Maryanna Saenko 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Director Pharmaceuticals Decline to Disclose 06b false 2020-10-20 false true true true false 0 28434938 28434938 0 The Total Offering amount and Total Amount Sold includes a $4,000,000 convertible promissory note. false 30 0 0 0 false Cambrian BioPharma Inc James G. Peyer James G. Peyer Chief Executive Officer 2021-05-06